DCX Systems Ltd
DCXINDIADCX Systems Ltd's price has outrun its earnings. −39.5% in a year against EPS −119.8% — the market is paying now for delivery later.
The sharpest disagreement: the price moved −39.5% in a year while annual EPS moved −119.8% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a downtrend (60 weeks in) while the P/E sits at the 99th percentile of its own 4-year range. Underneath, the last four quarters read deteriorating — profit −313.3% year on year, and −481% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
DCX Systems Ltd trades at ₹167, in a downtrend and 60 weeks into that stage. That is −14.5% against its own 200-day average. It sits at 9% of a 52-week range of ₹160 to ₹242. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (13 weeks and counting).
Today the stock is in a downtrend — week 60 of stage 4, confirmed. At ₹167 it trades −14.5% versus its 200-day average and sits at 9% of its 52-week range (₹160–₹242).
Against the market, two honest reads. Cumulative: over the last 3.8 years the stock moved −46% while the NIFTY 500 moved +46% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (13 weeks and counting; last ahead the week of 2026-06-24) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
DCX Systems Ltd trades at 169.8× P/E, about the priciest it has ever traded. Its long-run median P/E is 49.2×, measured across 3.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 169.8× is about the priciest it has ever traded, against a long-run median of 49.2× measured over 3.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −119.8% against a −39.5% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 3y, of the −21.1%/yr price move, ~−46.5%/yr came from earnings growth and ~+25.4 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
DCX Systems Ltd reads as deteriorating on its fundamental arc. Deteriorating — revenue, profit and EPS growth are shrinking (revenue growth −46.5% latest against +7.7% at its 12-quarter best), ROCE slipping at 1.0%. The read is built from 8 quarters across 4 curves, on partial evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −31.5% | −16.0% | +3.0% | — |
| Share price | −39.5% | −21.1% | — | — |
4-Factor Sector Score
24.0/100 — rank 24 of 25 in Aerospace & Defence - Equipments · 71% evidence confidence
DCX Systems Ltd scores 24.0 out of 100 against the 25 companies it is compared with in Aerospace & Defence - Equipments, ranking 24. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 5.9 + 4.2 + 10 + 3.9 = 24. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
DCX Systems Ltd reported ₹103 Cr of revenue in the Jun 26 quarter, −53.6% year on year. Over 5 years it has compounded at 3.0% a year. The last full year, FY26, came in at ₹743 Cr. The last four reported quarters add to ₹624 Cr.
FY26 revenue came in at ₹743 Cr (−31.5% on the year), capping 5 years at 3.0% compound. The latest quarter (Jun 26) printed ₹103 Cr, −53.6% year on year.
Pace check: the last four quarters averaged −39.2% growth against the decade's 3.0% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −46.5% over the last 4 quarters against −33.0%/yr over the last 8 — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
DCX Systems Ltd's operating margin is −10.4% in the Jun 26 quarter, −10.9 percentage points against the same quarter a year ago. Across 6 fiscal years the operating margin has ranged −2.3% to 7.0%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is −10.4%, −10.9 pp against the same quarter a year ago. Across 6 fiscal years the operating margin has ranged −2.3%–7.0%.
🚨 Why the margin moved: operating margin went −10.9 pp year on year while gross margin went +1.6 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
DCX Systems Ltd posted a net loss of ₹8.7 Cr in the Jun 26 quarter. The full FY26 year was a loss of ₹8.0 Cr. That loss is 8.4% of the quarter's revenue. The same quarter a year earlier earned ₹4.1 Cr. 4 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹−8.7 Cr, −313.3% year on year. On the full year, FY26 printed ₹−8.0 Cr (−120.5%).
🚨 Why profit moved: revenue contributed −53.6% and the margin −10.9 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −203.1% vs revenue −39.2%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years −481% of DCX Systems Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹2.0 Cr of operating cash against ₹−8.0 Cr of profit. After ₹152 Cr of capital spending, ₹−150 Cr was left as free cash.
FY26: operating cash of ₹2.0 Cr against reported profit of ₹−8.0 Cr, leaving free cash of ₹−150 Cr after ₹152 Cr of capital spending. Across the last 3 fiscal years the conversion rate is −481% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at −481%: the cash cycle stretched 193 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 193 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
DCX Systems Ltd's cash conversion cycle runs 242 days in FY26, up from 49 days in FY21. Capital spending ran ₹497 Cr over the last 3 years. At FY26 sales of ₹743 Cr each day of that cycle holds about ₹2.0 Cr, so roughly ₹493 Cr sits inside the business at any moment.
FY26: debtors at 66 days, inventory at 289 days — roughly 9.5 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 242 days, looser than FY21's 49.
The full loop: cash goes out to suppliers and production on day 0; stock waits 289 days to sell; customers pay about 66 days after that; and suppliers themselves are paid at 113 days — netting out to the 242-day cycle.
In money terms: at FY26 sales of ₹743 Cr, each day of the cycle holds about ₹2.0 Cr — so the 242-day loop keeps roughly ₹493 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹497 Cr over the last 3 fiscal years against ₹33.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
DCX Systems Ltd earns a ROCE of 1% in FY26. Return on invested capital clears the cost of that capital by −15.9 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −1.1% net margin on 0.35× asset turns.
FY26 ROCE is 1%.
🚨 Why the return is what it is — the wiring (FY26): −1.1% net margin × 0.35× asset turns × 1.39× balance-sheet leverage ≈ −0.5% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: −3.9% − 12.0% = a −15.9 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
DCX Systems Ltd carries total debt of ₹3.0 Cr against shareholder equity of ₹1,513 Cr as of Mar 26, a debt-to-equity of 0.00 — effectively unlevered. On the annual view that ratio went from 2.89 in FY21 to 0.00 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹3.0 Cr against shareholder equity of ₹1,513 Cr — a debt-to-equity of 0.00. On the annual view, debt-to-equity went from 2.89 (FY21) to 0.00 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 7.6 points of DCX Systems Ltd over 8 quarters, the biggest move on the register. That takes promoters to 52.2% of the company. Domestic institutions moved −6.2 points over the same window, to 2.7%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −7.6 points over 8 quarters to 52.2%; Domestic institutions: −6.2 points over 8 quarters to 2.7%; Foreign institutions: +0.4 points over 8 quarters to 1.7%.
🚨 Why the register moved: promoters drove it (−7.6 points), alongside domestic institutions (−6.2 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
DCX Systems Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Sigma Advanced System LtdSIGMAADV | 77.9/100Favorable setup82% evidence | LEADER | 28.4/35 Revenue 100% · PAT 20.3% · OPM change 307 pp 95% evidence | 17.2/25 ROCE 60.8% · OPM 16% 76% evidence | 12.5/20 P/E 95.1× · PEG — 50% evidence | 19.8/20 RS sector 113.1% · RS bench 161.3% · 1Y 481.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 28.4 + 17.2 + 12.5 + 19.8 = 77.9 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Paras Defence and Space Technologies LtdPARAS | 70.7/100Favorable setup82% evidence | LEADER | 25.8/35 Revenue 36.6% · PAT 54.8% · OPM change 2 pp 95% evidence | 17.1/25 ROCE 17.2% · OPM 25% 76% evidence | 9.0/20 P/E 125× · PEG — 50% evidence | 18.8/20 RS sector 29.1% · RS bench 66.5% · 1Y 117.2%12 of 12 weeks ahead 100% evidence |
| Exact sum: 25.8 + 17.1 + 9 + 18.8 = 70.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3MTAR Technologies LtdMTARTECH | 67.2/100Favorable setup90% evidence | TURNING | 30.4/35 Revenue 53.5% · PAT 100% · OPM change 6 pp 100% evidence | 15.3/25 ROCE 15.1% · OPM 24% 100% evidence | 8.0/20 P/E 165× · PEG — 50% evidence | 13.5/20 RS sector 29.8% · RS bench 63% · 1Y 419.4%5 of 12 weeks ahead 100% evidence |
| Exact sum: 30.4 + 15.3 + 8 + 13.5 = 67.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Azad Engineering LtdAZAD | 64.0/100Mixed-positive evidence93% evidence | LEADER | 24.2/35 Revenue 29% · PAT 41.4% · OPM change 1 pp 100% evidence | 12.8/25 ROCE 11.9% · OPM 37% 100% evidence | 8.2/20 P/E 132× · PEG 2.29 65% evidence | 18.8/20 RS sector 15.1% · RS bench 50.7% · 1Y 80.6%10 of 12 weeks ahead 100% evidence |
| Exact sum: 24.2 + 12.8 + 8.2 + 18.8 = 64 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Rossell Techsys LtdROSSTECH | 62.9/100Mixed-positive evidence83% evidence | BREAKING OUT | 28.8/35 Revenue 82.9% · PAT 68.8% · OPM change 1.8 pp 100% evidence | 8.0/25 ROCE 11.5% · OPM 14.4% 100% evidence | 8.9/20 P/E 173× · PEG — 15% evidence | 17.2/20 RS sector 13.1% · RS bench 48.2% · 1Y 69.8%8 of 12 weeks ahead 100% evidence |
| Exact sum: 28.8 + 8 + 8.9 + 17.2 = 62.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Sika Interplant Systems LtdSIKA | 62.4/100Mixed-positive evidence94% evidence | BREAKING OUT | 19.1/35 Revenue 0.5% · PAT 9.8% · OPM change 1.1 pp 100% evidence | 21.9/25 ROCE 34.6% · OPM 19.5% 100% evidence | 13.0/20 P/E 66.4× · PEG 1.01 100% evidence | 8.4/20 RS sector -10.2% · RS bench 7.8% · 1Y -4.3%8 of 9 weeks ahead 70% evidence |
| Exact sum: 19.1 + 21.9 + 13 + 8.4 = 62.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Vinyas Innovative Technologies LtdVINYAS | 60.0/100Thin evidence · provisional57% evidence | BREAKING OUT | 21.7/35 Revenue 65% · PAT 100% · OPM change 3 pp 48% evidence | 19.0/25 ROCE 21.4% · OPM 13% 95% evidence | 10.8/20 P/E 63.1× · PEG — 15% evidence | 8.5/20 RS sector -17.6% · RS bench 31.3% · 1Y 24.9%11 of 11 weeks ahead 70% evidence |
| Exact sum: 21.7 + 19 + 10.8 + 8.5 = 60 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8Data Patterns (India) LtdDATAPATTNS | 58.3/100Mixed-positive evidence100% evidence | LEADER | 22.8/35 Revenue 33.9% · PAT 24.2% · OPM change -5 pp 100% evidence | 19.8/25 ROCE 21.9% · OPM 27% 100% evidence | 3.0/20 P/E 100× · PEG 3.94 100% evidence | 12.7/20 RS sector 7.7% · RS bench 40.5% · 1Y 95%10 of 12 weeks ahead 100% evidence |
| Exact sum: 22.8 + 19.8 + 3 + 12.7 = 58.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 9Jaykay Enterprises LtdJAYKAY | 54.3/100Mixed-positive evidence74% evidence | ASLEEP | 29.0/35 Revenue 100% · PAT 100% · OPM change 1.8 pp 95% evidence | 8.1/25 ROCE 8.2% · OPM 14.2% 95% evidence | 11.1/20 P/E 61.2× · PEG — 15% evidence | 6.1/20 RS sector -20.9% · RS bench 1.6% · 1Y 13.3%1 of 10 weeks ahead 70% evidence |
| Exact sum: 29 + 8.1 + 11.1 + 6.1 = 54.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -20.9% and the one-year return is 13.3%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 10Astra Microwave Products LtdASTRAMICRO | 53.5/100Mixed-positive evidence100% evidence | LEADER | 16.0/35 Revenue 3.9% · PAT 17.4% · OPM change -1 pp 100% evidence | 17.7/25 ROCE 20.3% · OPM 19% 100% evidence | 4.8/20 P/E 84.4× · PEG 3.3 100% evidence | 15.0/20 RS sector 7.8% · RS bench 39.8% · 1Y 66.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 16 + 17.7 + 4.8 + 15 = 53.5 · Decision use: Price leads the evidence: RS versus the benchmark is 39.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 11Hindustan Aeronautics LtdHAL | 52.3/100Mixed-positive evidence100% evidence | BREAKING OUT | 13.9/35 Revenue 7.4% · PAT 12.2% · OPM change 1 pp 100% evidence | 20.4/25 ROCE 32% · OPM 28% 100% evidence | 8.2/20 P/E 35.2× · PEG 3.54 100% evidence | 9.8/20 RS sector -17.1% · RS bench 11.6% · 1Y 11.4%8 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 20.4 + 8.2 + 9.8 = 52.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Apollo Micro Systems LtdAPOLLO | 51.8/100Mixed-positive evidence100% evidence | FADING | 19.6/35 Revenue 68.8% · PAT 74.2% · OPM change -10 pp 100% evidence | 13.4/25 ROCE 14.5% · OPM 21% 100% evidence | 7.2/20 P/E 129× · PEG 1.6 100% evidence | 11.6/20 RS sector 6.4% · RS bench 38.8% · 1Y 38.6%8 of 12 weeks ahead 100% evidence |
| Exact sum: 19.6 + 13.4 + 7.2 + 11.6 = 51.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Dynamatic Technologies LtdDYNAMATECH | 48.5/100Mixed-negative evidence83% evidence | TURNING | 18.3/35 Revenue 17.3% · PAT 0% · OPM change 3 pp 100% evidence | 9.3/25 ROCE 10.2% · OPM 13% 100% evidence | 9.2/20 P/E 140× · PEG — 15% evidence | 11.7/20 RS sector -6.1% · RS bench 25% · 1Y 82.9%3 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 9.3 + 9.2 + 11.7 = 48.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Mishra Dhatu Nigam LtdMIDHANI | 45.5/100Mixed-negative evidence100% evidence | TURNING | 16.6/35 Revenue 18.2% · PAT 13.4% · OPM change -5 pp 100% evidence | 11.5/25 ROCE 11.3% · OPM 15% 100% evidence | 7.5/20 P/E 62.1× · PEG 5.62 100% evidence | 9.9/20 RS sector -9.5% · RS bench 20.5% · 1Y 18.7%4 of 12 weeks ahead 100% evidence |
| Exact sum: 16.6 + 11.5 + 7.5 + 9.9 = 45.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Bharat Electronics LtdBEL | 45.0/100Mixed-negative evidence100% evidence | TURNING | 14.7/35 Revenue 19.8% · PAT 11.8% · OPM change -3 pp 100% evidence | 19.3/25 ROCE 36.4% · OPM 25% 100% evidence | 7.5/20 P/E 48.1× · PEG 3.54 100% evidence | 3.5/20 RS sector -27.8% · RS bench -2.2% · 1Y 9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.7 + 19.3 + 7.5 + 3.5 = 45 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Ideaforge Technology LtdIDEAFORGE | 44.5/100Mixed-negative evidence74% evidence | ASLEEP | 26.7/35 Revenue 100% · PAT 100% · OPM change 152.7 pp 74% evidence | 1.3/25 ROCE -2.8% · OPM 3.4% 100% evidence | 8.5/20 P/E 928× · PEG — 15% evidence | 8.0/20 RS sector -3.5% · RS bench 24.1% · 1Y 44.1%7 of 12 weeks ahead 100% evidence |
| Exact sum: 26.7 + 1.3 + 8.5 + 8 = 44.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17High Energy Batteries (India) Ltd504176 | 43.3/100Mixed-negative evidence67% evidence | TURNING | 6.7/35 Revenue 1.5% · PAT -3.5% · OPM change -32.1 pp 95% evidence | 14.2/25 ROCE 20.4% · OPM -26.5% 76% evidence | 12.3/20 P/E 38.9× · PEG — 50% evidence | 10.1/20 RS sector — · RS bench 4.7% · 1Y —4 of 4 weeks ahead 25% evidence |
| Exact sum: 6.7 + 14.2 + 12.3 + 10.1 = 43.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Zen Technologies LtdZENTEC | 41.4/100Mixed-negative evidence69% evidence | FADING | 5.1/35 Revenue -23.4% · PAT -27.8% · OPM change -14 pp 95% evidence | 16.7/25 ROCE 16.2% · OPM 27% 76% evidence | 10.2/20 P/E 85.6× · PEG — 15% evidence | 9.4/20 RS sector -6.6% · RS bench 13.1% · 1Y 16.5%5 of 10 weeks ahead 70% evidence |
| Exact sum: 5.1 + 16.7 + 10.2 + 9.4 = 41.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19BEML LtdBEML | 40.5/100Mixed-negative evidence91% evidence | BREAKING OUT | 15.9/35 Revenue 12.8% · PAT -40.1% · OPM change 8.2 pp 74% evidence | 3.5/25 ROCE 7.7% · OPM 0.2% 100% evidence | 10.7/20 P/E 94.4× · PEG 1.18 100% evidence | 10.4/20 RS sector -17% · RS bench 12% · 1Y -0.9%6 of 12 weeks ahead 100% evidence |
| Exact sum: 15.9 + 3.5 + 10.7 + 10.4 = 40.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Bharat Dynamics LtdBDL | 35.2/100Mixed-negative evidence93% evidence | TURNING | 12.1/35 Revenue -18.7% · PAT -7.1% · OPM change 33 pp 100% evidence | 13.3/25 ROCE 13.8% · OPM 15% 100% evidence | 5.9/20 P/E 83.8× · PEG 4.44 65% evidence | 3.9/20 RS sector -35.7% · RS bench -12.4% · 1Y -17.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 12.1 + 13.3 + 5.9 + 3.9 = 35.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21AXISCADES Technologies LtdAXISCADES | 33.1/100Adverse evidence93% evidence | ASLEEP | 11.9/35 Revenue 3.5% · PAT -55% · OPM change -2.3 pp 100% evidence | 3.9/25 ROCE 3.6% · OPM 4.7% 100% evidence | 10.9/20 P/E 238× · PEG 1.39 65% evidence | 6.4/20 RS sector -12% · RS bench 17% · 1Y 27.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 11.9 + 3.9 + 10.9 + 6.4 = 33.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Avantel LtdAVANTEL | 32.1/100Adverse evidence83% evidence | ASLEEP | 9.9/35 Revenue -3.2% · PAT -67.2% · OPM change 4.6 pp 100% evidence | 10.2/25 ROCE 9.6% · OPM 24.8% 100% evidence | 8.6/20 P/E 242× · PEG — 15% evidence | 3.4/20 RS sector -26.5% · RS bench -1.1% · 1Y -11.6%4 of 12 weeks ahead 100% evidence |
| Exact sum: 9.9 + 10.2 + 8.6 + 3.4 = 32.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23NIBE LtdNIBE | 24.1/100Adverse evidence66% evidence | FADING | 3.0/35 Revenue -5.2% · PAT -80% · OPM change -24 pp 95% evidence | 5.4/25 ROCE 4.8% · OPM -15% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.7/20 RS sector -29.8% · RS bench 4.7% · 1Y 7.1%7 of 11 weeks ahead 70% evidence |
| Exact sum: 3 + 5.4 + 10 + 5.7 = 24.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24DCX Systems Ltdthis pageDCXINDIA | 24.0/100Adverse evidence71% evidence | BASING | 5.9/35 Revenue -46.5% · PAT -80% · OPM change -10.9 pp 95% evidence | 4.2/25 ROCE 0.9% · OPM -10.4% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.9/20 RS sector -27.1% · RS bench -12.3% · 1Y -37.9%1 of 10 weeks ahead 70% evidence |
| Exact sum: 5.9 + 4.2 + 10 + 3.9 = 24 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Aequs LtdAEQUS | 39.1/100Thin evidence · provisional35% evidence | BREAKING OUT | 14.9/35 Revenue — · PAT — · OPM change -7.3 pp 45% evidence | 4.2/25 ROCE 1.7% · OPM 3.7% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —12 of 12 weeks ahead 0% evidence |
| Exact sum: 14.9 + 4.2 + 10 + 10 = 39.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is DCX Systems Ltd's share price today?
DCX Systems Ltd trades at ₹167, −39.5% over the past year. The company is valued at ₹1,856 Cr. The stock sits at 9% of its 52-week range of ₹160–₹242, −14.5% versus its 200-day average. On the tape, the price is in a downtrend, 60 weeks in. — as of 11 September 2026.
What were DCX Systems Ltd's latest quarterly results?
DCX Systems Ltd reported revenue of ₹103 Cr and a net loss of ₹8.7 Cr for the Jun 26 quarter. Revenue fell 53.6% and profit fell 313.3% year on year. Earnings per share were ₹−0.78. The operating margin was −10.4%, 10.9 pp lower than a year earlier. — as of 11 September 2026.
What is DCX Systems Ltd's revenue?
DCX Systems Ltd reported revenue of ₹103 Cr in the Jun 26 quarter, −53.6% year on year. For the full FY26 fiscal year, revenue was ₹743 Cr (−31.5%). Over the last 5 years revenue compounded at 3.0% a year. — as of 11 September 2026.
What is DCX Systems Ltd's profit?
DCX Systems Ltd earned ₹−8.7 Cr of net profit in the Jun 26 quarter, −313.3% year on year. Full-year FY26 profit was ₹−8.0 Cr. The operating margin ran −10.4% in the latest quarter. — as of 11 September 2026.
What is DCX Systems Ltd's market cap?
DCX Systems Ltd's market capitalisation is ₹1,856 Cr at a share price of ₹167. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is DCX Systems Ltd's P/E ratio?
DCX Systems Ltd trades at a P/E of 169.8×, at the 99th percentile of its own 4-year range, against a long-run median of 49.2×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does DCX Systems Ltd pay a dividend?
No — DCX Systems Ltd has recorded a dividend payout of 0% of profit in each of its last 6 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 11 September 2026.
Is DCX Systems Ltd overvalued?
On its own history, DCX Systems Ltd looks expensive: its P/E of 169.8× sits at the 99th percentile of its 4-year range (long-run median 49.2×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is DCX Systems Ltd growing?
Not right now — DCX Systems Ltd's latest numbers are shrinking: latest-quarter revenue −53.6% year on year, profit −313.3%, and the margin −10.9 pp at −10.4%. The earnings engine currently reads: deteriorating — as of 11 September 2026.
How is DCX Systems Ltd performing?
DCX Systems Ltd is in a downtrend, 60 weeks in. Its latest quarter's revenue fell 53.6% and profit fell 313.3% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 13 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is DCX Systems Ltd in?
Deteriorating — revenue, profit and EPS growth are shrinking (revenue growth −46.5% latest against +7.7% at its 12-quarter best), ROCE slipping at 1.0%. The read comes from the last 12 quarters of growth (revenue growth −46.5% latest, profit growth −151.1% latest, eps growth −151.3% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is DCX Systems Ltd in an uptrend?
No — the price is in a downtrend (week 60 of stage 4), trading −14.5% versus its 200-day average and at 9% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is DCX Systems Ltd beating the market?
Not lately — on a trailing-13-week view DCX Systems Ltd is currently behind the NIFTY 500 (13 weeks and counting; last ahead the week of 2026-06-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 3.8 years the stock moved −46% against the NIFTY 500's +46% — behind the index over the full window. — as of 11 September 2026.
Will DCX Systems Ltd's share price go up?
This page publishes no price forecast for DCX Systems Ltd. What it measures instead: the share price is ₹167, the price is in a downtrend 60 weeks in. Its P/E of 169.8× sits at the 99th percentile of its own 4-year range. — as of 11 September 2026.
Who owns DCX Systems Ltd?
Promoters hold 52.2% of DCX Systems Ltd, foreign institutions 1.7%, domestic institutions 2.7% and the public 43.4% (latest quarter). The biggest move on the register over the last two years: Promoters cut 7.6 points over 8 quarters. — as of 11 September 2026.
Does DCX Systems Ltd have too much debt?
No — DCX Systems Ltd's debt-to-equity is 0.00, and operating profit covers the interest bill −6×. FY26 borrowings were ₹3.0 Cr against equity of ₹1,513 Cr. The returns on this page are earned, not borrowed — as of 11 September 2026.
What is DCX Systems Ltd's capex?
DCX Systems Ltd spent ₹497 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹152 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is DCX Systems Ltd's cash flow?
DCX Systems Ltd generated ₹2.0 Cr of operating cash flow in FY26 and ₹−150 Cr of free cash flow after ₹152 Cr of capital spending. Reported profit that year was ₹−8.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is DCX Systems Ltd's profit real cash?
No — operating cash was negative over the last 3 fiscal years: DCX Systems Ltd consumed cash while reporting profit. In FY26, operating cash was ₹2.0 Cr against reported profit of ₹−8.0 Cr. Cash-flow resolution is annual — as of 11 September 2026.
Where is DCX Systems Ltd in its business cycle?
DCX Systems Ltd's FY26 operating margin was −2.3%, against a 6-year band of −2.3%–7.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran −10.4%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What could break the DCX Systems Ltd story?
The sharpest disagreement: the price moved −39.5% in a year while annual EPS moved −119.8% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is DCX Systems Ltd a stock worth studying right now?
This is not investment advice. The machine read: DCX Systems Ltd's price has outrun its earnings. −39.5% in a year against EPS −119.8% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!